Evidence map›Paper›PMID 38196830›Full record

ArticleInternational journal of nephrology and renovascular disease2024

Impact of Sodium-Glucose Cotransporter-2 Inhibitors in the Management of Chronic Kidney Disease: A Middle East and Africa Perspective.

Ahmed Fathi Elkeraie, Saeed Al-Ghamdi, Ali K Abu-Alfa, Torki Alotaibi, Ali Jasim AlSaedi, Abdulkareem AlSuwaida, Mustafa Arici, Tevfik Ecder, Mohammad Ghnaimat, Mohamed Hany Hafez and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of nephrology and renovascular disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ahmed Fathi ElkeraieDepartment of Internal Medicine and Nephrology, Alexandria University, Alexandria, Egypt.ORCID 0000-0002-0305-2290
Saeed Al-GhamdiDepartment of Medicine, College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Ali K Abu-AlfaDepartment of Internal Medicine, Division of Nephrology and Hypertension, American University of Beirut, Beirut, Lebanon.
Torki AlotaibiTransplant Nephrology, Hamed Al-Essa Organ Transplant Center, Sabah Health Region, Kuwait City, Kuwait.
Ali Jasim AlSaediDepartment of Nephrology, College of Medicine, University of Baghdad, Nephrology and Transplantation Center, Medical City Complex, Baghdad, Iraq.
Abdulkareem AlSuwaidaDepartment of Medicine, King Saud University, Riyadh, Saudi Arabia.
Mustafa AriciDepartment of Nephrology, Faculty of Medicine, Hacettepe University, Altındağ, Ankara, Turkey.
Tevfik EcderDepartment of Medicine, Istinye University; Division of Nephrology, Topkapı, Istanbul, Turkey.
Mohammad GhnaimatDepartment of Nephrology, Specialty Hospital, Jaber Ibn Hayyan St. Shmeisani, Amman, Jordan.
Mohamed Hany HafezDepartment of Nephrology and Medicine, Cairo University, Cairo, Egypt.
Mohamed H HassanDepartment of Medicine, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
Tarik SqalliDepartment of Nephrology, Moroccan Society of Nephrology, Casablanca, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic kidney disease (CKD) is a major public health concern in the Middle East and Africa (MEA) region and a leading cause of death in patients with type 2 diabetes mellitus (T2DM) and hypertension. Early initiation of sodium-glucose cotransporter - 2 inhibitors (SGLT-2i) and proper sequencing with renin-angiotensin-aldosterone system inhibitors (RAASi) in these patients may result in better clinical outcomes due to their cardioprotective properties and complementary mechanisms of action. In this review, we present guideline-based consensus recommendations by experts from the MEA region, as practical algorithms for screening, early detection, nephrology referral, and treatment pathways for CKD management in patients with hypertension and diabetes mellitus. This study will help physicians take timely and appropriate actions to provide better care to patients with CKD or those at high risk of CKD.

Indexed as

chronic kidney diseasenephrology referralscreeningsodium-glucose cotransporter-2 inhibitors

Identifiers

PMID38196830
PMCPMC10771977

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.